BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7002778)

  • 1. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 2. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
    Mortelmans K; Haworth S; Lawlor T; Speck W; Tainer B; Zeiger E
    Environ Mutagen; 1986; 8 Suppl 7():1-119. PubMed ID: 3516675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a streamlined bacterial mutagenicity assay, the MINISCREEN.
    Brooks TM
    Mutagenesis; 1995 Sep; 10(5):447-8. PubMed ID: 8544759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Salmonella mutagenicity assay on fenticonazole, a new antifungal imidazole derivative.
    Veronese M; Barzaghi D; Bertoncini A; Zadro M
    Arzneimittelforschung; 1981; 31(12):2140-2. PubMed ID: 7037010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro mammalian cell genotoxicity assays: their use and interpretation.
    McGregor D
    Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines].
    Khudoleĭ VV; Malaveille C; Bartsch H
    Vopr Onkol; 1981; 27(11):59-62. PubMed ID: 7039103
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    Mutat Res; 1980 Jul; 76(1):1-50. PubMed ID: 6993936
    [No Abstract]   [Full Text] [Related]  

  • 9. International Commission for Protection against Environmental Mutagens and Carcinogens. Committee 2 Final Report. Mutagenesis testing as an approach to carcinogenesis.
    Mutat Res; 1982 Jul; 99(1):73-91. PubMed ID: 6214712
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutagenicity of carcinogenic mycotoxins in Salmonella typhimurium.
    Ueno Y; Kubota K; Ito T; Nakamura Y
    Cancer Res; 1978 Mar; 38(3):536-42. PubMed ID: 342092
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation of tests for carcinogenicity.
    Purchase IF
    IARC Sci Publ; 1980; (27):343-9. PubMed ID: 7002781
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prospects for the use of short-term tests in primary cancer prevention].
    Khudoleĭ VV; Pliss GB
    Vopr Onkol; 1984; 30(8):3-12. PubMed ID: 6385476
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenic activity of chemicals previously tested for carcinogenicity in the National Cancer Institute bioassay program.
    Dunkel VC; Simmon VF
    IARC Sci Publ; 1980; (27):283-301. PubMed ID: 7002779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation of procarcinogens by subcellular enzyme fractions in the C3H 10T1/2 and BALB/c 3T3 cell transformation systems.
    Schechtman LM
    IARC Sci Publ; 1985; 67():137-62. PubMed ID: 3913640
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the Salmonella umu test with 83 NTP chemicals.
    Yasunaga K; Kiyonari A; Oikawa T; Abe N; Yoshikawa K
    Environ Mol Mutagen; 2004; 44(4):329-45. PubMed ID: 15476194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of dominant lethal mutations in laboratory rats following cycle blockade by Suisynchron premix. 4. Mutagenicity studies of the gestogen Suisynchron in bacterial test systems].
    Schwerin M; Braun R; Schöneich J; Kauffold P
    Arch Exp Veterinarmed; 1984 Mar; 38(2):272-7. PubMed ID: 6430254
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutagenicity of the dihydrodiols and bay-region diol-epoxides of benzo(c)phenanthrene in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Croisy-Delcey M; Ittah Y; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Aug; 40(8 Pt 1):2876-83. PubMed ID: 6992991
    [No Abstract]   [Full Text] [Related]  

  • 19. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.